38961-21-6

Basic information

• Product Name: 2-(4-(Benzyloxy)phenyl)-N-methylethanamine
• Synonyms: [2-(4-BENZYLOXY-PHENYL)-ETHYL]-METHYL-AMINE;2-(4-(Benzyloxy)phenyl)-N-methylethanamine;N-Methyl-4-(benzyloxy)phenethylamine;N-Methyl-4-(benzyloxy)-benzeneethanaMine
• CAS NO: 38961-21-6
• Molecular Formula: C₁₆H₁₉NO
• Molecular Weight: 241.33
• Mol File: 38961-21-6.mol
• Article Data: 5

Chemical Properties

• Boiling Point: 371.82 °C at 760 mmHg
• Flash Point: 155.342 °C
• Appearance: /
• Density: 1.038
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.561
• PKA: 10.38±0.10(Predicted)
• CAS DataBase Reference: 2-(4-(Benzyloxy)phenyl)-N-methylethanamine(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(4-(Benzyloxy)phenyl)-N-methylethanamine(38961-21-6)
• EPA Substance Registry System: 2-(4-(Benzyloxy)phenyl)-N-methylethanamine(38961-21-6)

Safety Data

• Hazardous Substances Data: 38961-21-6(Hazardous Substances Data)

Usage

General Description

2-(4-(Benzyloxy)phenyl)-N-methylethanamine is a chemical with the molecular formula C17H19NO and a molecular weight of 253.34 g/mol. It is an amine compound with a substituent of a benzyloxy group attached to a phenyl ring. This chemical is a derivative of N-methylethanamine and is used in scientific research and pharmaceutical development. It may have potential applications in the field of medicinal chemistry and drug discovery due to its structural properties and potential biological activity.

InChI:InChI=1/C16H19NO/c1-17-12-11-14-7-9-16(10-8-14)18-13-15-5-3-2-4-6-15/h2-10,17H,11-13H2,1H3

Upstream product

• 13062-78-7 N-[2-(4-hydroxyphenyl)ethyl]formamide 
• 24958-41-6 N-methyl-O-benzyltyramine hydochloride 
• 60-19-5 tyramine hydrochloride 
• 68898-75-9 N-Formyl-2-(4-benzyloxyphenyl)ethylamin 
• 24958-40-5 p-benzyloxyphenylacetic acid N-methylamide 
• 100-44-7 benzyl chloride 

Downstream Products

• 24958-43-8 5-benzyloxy-N-[2-(4-benzyloxy-phenyl)-ethyl]-2-bromo-4-methoxy-N-methylbenzamide 
• 68898-82-8 (E)-3-[4-(2-{[(S)-2-(tert-Butoxycarbonyl-methyl-amino)-4-methyl-pentanoyl]-methyl-amino}-ethyl)-phenoxy]-acrylic acid benzyl ester 
• 68898-81-7 (E)-3-(4-{2-[((S)-2-tert-Butoxycarbonylamino-4-methyl-pentanoyl)-methyl-amino]-ethyl}-phenoxy)-acrylic acid benzyl ester 
• 68898-84-0 3-[4-(2-{[(S)-2-(tert-Butoxycarbonyl-methyl-amino)-4-methyl-pentanoyl]-methyl-amino}-ethyl)-phenoxy]-propionic acid 
• 68898-83-9 3-(4-{2-[((S)-2-tert-Butoxycarbonylamino-4-methyl-pentanoyl)-methyl-amino]-ethyl}-phenoxy)-propionic acid 
• 68898-79-3 ((S)-1-{[2-(4-Hydroxy-phenyl)-ethyl]-methyl-carbamoyl}-3-methyl-butyl)-methyl-carbamic acid tert-butyl ester 
• 68898-78-2 ((S)-1-{[2-(4-Hydroxy-phenyl)-ethyl]-methyl-carbamoyl}-3-methyl-butyl)-carbamic acid tert-butyl ester 
• 68898-77-1 ((S)-1-{[2-(4-Benzyloxy-phenyl)-ethyl]-methyl-carbamoyl}-3-methyl-butyl)-methyl-carbamic acid tert-butyl ester 

Relevant articles and documents

MAO-B SELECTIVE INHIBITOR COMPOUNDS, PHARMACEUTICAL COMPOSITIONS THEREOF AND USES THEREOF

Described herein are a series of compounds having the structure of Formula I for use in the inhibition of MAO and uses thereof for the treatment of a barrier disease, obesity, solid epithelial cell tumor metastasis, diabetes, an auto-immune and inflammatory disease or a cardiometabolic disorder.

Preparation of (-)-galantamine hydrobromide

A process for preparing (?)-galantamine hydrobromide.

Cyclopeptide alkaloids. Synthesis of the ring system and its ion affinity

-